Skip to main content

vTv Therapeutics Inc.

VTVT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001641489

No open-market purchases or sales by vTv Therapeutics Inc. insiders were filed in the last 90 days; 45 institutions reported holding it in 13F filings for Q2 2026, worth $60.5M in total; no superinvestor holds it.

13F holders, Q4 2023

Institutional positions in vTv Therapeutics Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
14
−10 vs. Q3 2023
Shares held
68.7K
−11.4K (−14.2%) vs. Q3 2023Converted for a 1-for-40 split
Total value
$788.7K
−$741.5K (−48.5%) vs. Q3 2023
New holders
1
4 more added
Sold out
11
3 more reduced

1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting VTVT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2023: 14 institutions
Q1 2021: 48 institutionsQ2 2021: 42 institutionsQ3 2021: 31 institutionsQ4 2021: 29 institutionsQ1 2022: 25 institutionsQ2 2022: 23 institutionsQ3 2022: 27 institutionsQ4 2022: 30 institutionsQ1 2023: 24 institutionsQ2 2023: 20 institutionsQ3 2023: 25 institutionsQ4 2023: 14 institutionsQ1 2024: 19 institutionsQ2 2024: 19 institutionsQ3 2024: 20 institutionsQ4 2024: 17 institutionsQ1 2025: 21 institutionsQ2 2025: 21 institutionsQ3 2025: 23 institutionsQ4 2025: 27 institutionsQ1 2026: 35 institutionsQ2 2026: 45 institutions
Value heldQ4 2023: $788.7K
Q1 2021: $13.5MQ2 2021: $9.89MQ3 2021: $5.17MQ4 2021: $6.49MQ1 2022: $3.76MQ2 2022: $2.75MQ3 2022: $3.38MQ4 2022: $2.47MQ1 2023: $2.88MQ2 2023: $2.60MQ3 2023: $1.65MQ4 2023: $788.7KQ1 2024: $7.85MQ2 2024: $6.15MQ3 2024: $7.34MQ4 2024: $7.57MQ1 2025: $9.90MQ2 2025: $8.74MQ3 2025: $23.1MQ4 2025: $51.3MQ1 2026: $59.0MQ2 2026: $60.5M
Institutions holding VTVT and their total value by quarter
QuarterHoldersValue
Q2 202645$60.5M
Q1 202635$59.0M
Q4 202527$51.3M
Q3 202523$23.1M
Q2 202521$8.74M
Q1 202521$9.90M
Q4 202417$7.57M
Q3 202420$7.34M
Q2 202419$6.15M
Q1 202419$7.85M
Q4 202314$788.7K
Q3 202325$1.65M
Q2 202320$2.60M
Q1 202324$2.88M
Q4 202230$2.47M
Q3 202227$3.38M
Q2 202223$2.75M
Q1 202225$3.76M
Q4 202129$6.49M
Q3 202131$5.17M
Q2 202142$9.89M
Q1 202148$13.5M

Institutions, Q4 2023

Shares, value and share of portfolio for each institution holding vTv Therapeutics Inc.; share changes are against Q3 2023.

Institutions holding VTVT in Q4 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Samsara BioCapital, LLC40,888$470.2K0.07%00.0%UnchangedConverted for a 1-for-40 split
Vanguard Group Inc23,519$270.5K0.00%00.0%UnchangedConverted for a 1-for-40 split
BlackRock Inc.1,341$15.4K0.00%00.0%UnchangedConverted for a 1-for-40 split
Tower Research Capital LLC (TRC)1,070$12.3K0.00%+1,070New
Morgan Stanley840$9.66K0.00%00.0%UnchangedConverted for a 1-for-40 split
Royal Bank of Canada588$6.00K0.00%+581+7,927.3%AddedConverted for a 1-for-40 split
Focused Wealth Management, Inc250$2.88K0.00%00.0%UnchangedConverted for a 1-for-40 split
Advisor Group Holdings, Inc.50$5750.00%−50−50.0%ReducedConverted for a 1-for-40 split
Parallel Advisors, LLC38$4370.00%+1+1.3%AddedConverted for a 1-for-40 split
Wells Fargo & Company30$3460.00%−6−17.2%ReducedConverted for a 1-for-40 split
Cornerstone Planning Group LLC19$2190.00%+0+1.3%AddedConverted for a 1-for-40 split
Sunbelt Securities, Inc.15$1720.00%00.0%UnchangedConverted for a 1-for-40 split
Bank of America Corp1$120.00%−8−89.4%ReducedConverted for a 1-for-40 split
JPMorgan Chase & Co1$110.00%+0+17.6%AddedConverted for a 1-for-40 split
Geode Capital Management, LLC0$00.00%−5,903−100.0%Sold outConverted for a 1-for-40 split
State Street Corp0$00.00%−3,369−100.0%Sold outConverted for a 1-for-40 split
Northern Trust Corp0$00.00%−1,260−100.0%Sold outConverted for a 1-for-40 split
Two Sigma Securities, LLC0$00.00%−761−100.0%Sold outConverted for a 1-for-40 split
Simon Quick Advisors, LLC0$00.00%−750−100.0%Sold outConverted for a 1-for-40 split
Susquehanna International Group, LLP0$00.00%−507−100.0%Sold outConverted for a 1-for-40 split
Millennium Management LLC0$00.00%−265−100.0%Sold outConverted for a 1-for-40 split
Strengthening Families & Communities, LLC0$00.00%−172−100.0%Sold outConverted for a 1-for-40 split
Comerica Bank0$00.00%−25−100.0%Sold outConverted for a 1-for-40 split
BNP Paribas Arbitrage, SA0$00.00%−8−100.0%Sold outConverted for a 1-for-40 split
FMR LLC0$00.00%−0−100.0%Sold outConverted for a 1-for-40 split
Pathstone Family Office, LLC––––Not filed